Case-control study shows low-cost biomarkers aiding early intervention in adolescents with methamphetamine use disorder.
Adolescents with MUD demonstrate marked systemic inflammatory alterations detectable through routine hematological indices. These markers may serve as low-cost, clinically accessible biomarkers for identifying high-risk individuals and monitoring disease severity, with implications for early intervention and personalized treatment.
No takes yet. Share an insight, caveat, or question.
Elif Merve Kurt Tunagur (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: